SCHEMBL486427

SCHEMBL486427

CC1CN(C)C(=O)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12240486 1.00
SCHEMBL12240470 1.00
SCHEMBL20649458 0.78
SCHEMBL17920244 0.76 SMN1; SMN2 (0.32)
SCHEMBL17920231 0.76 SMN1; SMN2 (0.32)
SCHEMBL17920189 0.76 SMN1; SMN2 (0.32)
SCHEMBL2304187 0.73
SCHEMBL12513322 0.73
SCHEMBL22606207 0.73
SCHEMBL11696111 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 281 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150291623-A1 SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2015-10-15 US claimed
US-20120295897-A1 SPIRO-OXINDOLE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2012-11-22 US claimed
EP-2350090-A2 SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS Xenon Pharmaceuticals Inc. (CA) 2011-08-03 EP claimed
US-20100137299-A1 SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2010-06-03 US claimed
WO-2010045251-A2 SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS, INC. (CA) 2010-04-22 WO claimed
US-7186844-B2 Method for producing cyclic carbamate ester MITSUBISHI GAS CHEMICAL CO., INC. (JP) 2007-03-06 US claimed
US-20050154200-A1 Method for producing cyclic carbamate ester MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2005-07-14 US claimed
EP-0885941-B1 Ink jet inks containing oxazolidinones XEROX CORP (US) 2004-02-18 EP claimed
US-5882389-A WATER, COLOR AND OXAZOLIDINONE XEROX CORPORATION (US) 1999-03-16 US claimed
EP-0138539-B1 2-AZACYCLOALKYLTHIOPENEM DERIVATIVES PFIZER INC. (US) 1989-03-15 EP claimed
US-4772597-A ANTIBIOTICS PFIZER INC. (US) 1988-09-20 US claimed
EP-0138539-A1 2-Azacycloalkylthiopenem derivatives PFIZER INC. (US) 1985-04-24 EP claimed
US-20240158337-A1 GAS-PHASE OXIDATIVE COUPLING OF ALCOHOLS AND AMINES USING HETEROGENEOUS CATALYSTS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA 2024-05-16 US disclosed
US-11827738-B2 Thiol-ene-curing compositions MOMENTIVE PERFORMANCE MATERIALS GMBH (DE) 2023-11-28 US disclosed
US-11827738-B2 Thiol-ene-curing compositions MOMENTIVE PERFORMANCE MATERIALS GMBH (DE) 2023-11-28 US disclosed
US-20230295180-A1 PROTEIN DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2023-09-21 US disclosed
EP-0138539-B1 2-AZACYCLOALKYLTHIOPENEM DERIVATIVES PFIZER INC. (US) 1989-03-15 EP disclosed
US-4772597-A ANTIBIOTICS PFIZER INC. (US) 1988-09-20 US disclosed
EP-0263182-A1 ELECTROLYTIC SOLUTION FOR ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR PREPARED BY USING IT SANYO CHEMICAL INDUSTRIES LTD. (JP) 1988-04-13 EP disclosed
EP-0138539-A1 2-Azacycloalkylthiopenem derivatives PFIZER INC. (US) 1985-04-24 EP disclosed